Microsomal epoxide hydrolase (mEH) catalyses the hydrolysis of xenobiotic epoxides, including various epoxide derivatives of the procarcinogenic polyaromatic hydrocarbons. Levels of mEH enzymatic activity among different cell types and between individuals within the population vary considerably. Genetic polymorphisms within the structural region of the human mEH gene exist and appear to contribute to the population variance in functional expression. In this study, we used single strand conformational polymorphism analysis and direct DNA sequencing approaches to identify seven additional polymorphic sites within the upstream region of the mEH gene, spanning -743 to ⍣185 bp, relative to the transcription initiation site. Allelic frequencies and linkages of the polymorphic nucleotides were determined in 51 individuals using restriction fragment length polymorphism or competitive oligonucleotide priming assays. To determine the functional significance of the individual nucleotide substitutions, DNA fragments representing the variant alleles were cloned into the heterologous pBRAMScat2 reporter vector, transfected into HepG2 cells and assessed for reporter gene expression. Results indicated that certain of these polymorphic loci might differentially regulate transcription, with the maximum contribution of any of the variants modifying levels of reporter gene activity by~30%. These observations establish that genetic variation in the 5Ј flanking sequence of mEH gene is likely an additional contributing factor to the range of functional mEH expression existing in human populations.
Introduction
Microsomal epoxide hydrolase (mEH*, E.C. 3.3.2.3) catalyses, with broad substrate specificity, the conversion of highly reactive, and cytotoxic arene oxides and aliphatic epoxides to less toxic trans-dihydrodiols (1) . Substrates for mEH are principally xenobiotic epoxide metabolites generated by Phase I oxidation reactions. Therefore, mEH biotransformation typically results in detoxification and preparation for Phase II conjugation reactions. However, in certain cases, mEH also participates in bioactivation pathways, with a well-characterized example being the metabolic conversion of benzo [a] pyrene (a component of cigarette smoke) to the highly mutagenic (ϩ)-anti-7,8-diol-9,10-epoxide (2) .
The mEH enzyme is expressed in all tissues thus far examined (3, 4) with highest levels in the liver, kidney, and testis and 10-100-fold lower levels in the lung and lymphocytes (5) . Within cells, mEH is localized mainly to the endoplasmic reticulum where it can transiently associate with the cytochrome P-450 mixed function oxygenase system (6) . Endogenous substrates for mEH have not been readily identified. However, the mEH-catalysed hydrolysis of certain steroid epoxides (7) , indicates potential involvement in steroid metabolism. Additionally, the high degree of mEH structural conservation between several mammalian species (8) and apparent ubiquitous tissue expression imply an important role in cellular metabolism.
There is evidence for polymorphic mEH expression within the human population. Interindividual differences in mEH activity ranging in scale from several to 40-fold have been reported in various human tissue types (5, 9, 10) . Clinical studies have demonstrated associations between low mEH enzyme activity levels, and adverse drug responses or disease states. Among these are reports that low levels of mEH activity correlate with the occurrence of fetal hydantoin syndrome (11, 12) . Individuals displaying hepatotoxicity in response to phenytoin and acetaminophen exposure have decreased levels of mEH activity when compared to control subjects (13, 14) . In contrast, several other studies have not found an association between mEH expression or genotype, and adverse anticonvulsant drug responses (15) (16) (17) .
Heckbert et al. (18) reported a consistent, but statistically non-significant association between low mEH activity and the occurrence of lung and other smoking-related cancers. Recently, McGlynn et al. (19) reported the association of a mEH exon 3 polymorphism, which reduces enzyme activity in vitro, with the occurrence of hepatocellular carcinoma in an aflatoxin and hepatitis B-exposed population. Interestingly, Lancaster et al. (20) observed an association between the higher activity exon 3 allele and the occurrence of ovarian cancer. These findings imply mEH involvement in both prevention and potentiation of the carcinogenic process.
The molecular basis for variation in mEH activity has not been characterized completely. As indicated above, genetic polymorphisms have been identified within the coding region of the gene (15, 21) which result in amino acid substitutions at two positions (residue 113Tyr/His; residue 139Arg/His). In vitro expression analyses indicated that the corresponding proteins varied as much as 65% in relative activity (21) . However, these alterations were more likely the result of altered protein stability, and not enzyme specific activity. While these structural polymorphisms of the enzyme are likely biologically and clinically relevant by themselves, they do not appear to account for the complete spectrum of mEH activity variation within the population.
Many human genes, including cytochrome P450 2E1 (22) 
Materials and methods

PCR-SSCP analysis
Genomic DNA was obtained from a study of predominately Caucasian male workers in western Washington State (26) . DNA samples were PCR amplified and radiolabeled using the primer sequences and annealing temperatures shown in Table I , panel A. The locations of the PCR products within the mEH promoter, relative to the transcription start site (27) , also are indicated in Table I Table I for temperatures) and 72°C extension for 45 s. Reaction products were analysed by agarose gel electrophoresis to verify expected size. SSCP analyses were performed at room temperature using 6% acrylamide/7.5% glycerol gels and electrophoresed at 8-10 W for 14-18 h, as described by Orita et al. (28) . For analysis, gels were dried and subjected to autoradiography. 
DNA sequencing
Genomic DNA samples that exhibited unique patterns with SSCP analysis were PCR amplified, purified with Microcon-100 filters (Amicon, Beverly, MA) and sequenced on both strands using the fmolTM cycle sequencing system (Promega, Madison, WI). Sequence analysis employing Sequenase Version 2.0 T7 DNA polymerase (USB, Cleveland, OH) was used to verify plasmid identity (see below).
Genotype determination and allelic frequency
Genomic DNA samples were PCR-amplified with primers FP6 and RPS4 (Table I , panel B), ethanol precipitated, digested and analysed by agarose gel electrophoresis. Six of the identified polymorphic residues occurred within restriction enzyme recognition sites thereby allowing analyses by RFLP. Since RFLP analysis was not possible at one polymorphic site, a modification of competitive oligonucleotide priming (COP) analysis (29) was employed. The allele specific oligonucleotides (ASO), RP-362C and RP-362T (Table I , panel C) contained the variant base at the 3Ј end, rather than internally. Five ng of FP6/RPS4-derived PCR product obtained from each genomic DNA was used as a template in two separate PCR reactions containing 0.1 µM of each unlabeled ASO, 5ϫ10 5 dpm of either RP-362C or RP-362T 32 P-labeled ASO, 0.2 µM FPS3 and other PCR reagents as indicated above. PCR primers with perfect complementarity to the template DNA at the variable nucleotide are preferentially incorporated in the amplification reaction. Products were electrophoresed in 1.5% agarose gels which were dried and analysed by autoradiography. Hardy-Weinberg equilibrium was assessed for each polymorphic locus using the χ 2 test at significance level of P Ͻ 0.05.
Plasmid construction and preparation.
Fragments of mEH 5Ј DNA were generated by PCR amplification of genomic DNA using the primer set shown in Table I , panel B. In several instances, other amplification primers containing mismatches relative to the template were used to create restriction sites and facilitate cloning. The PCR products were digested with appropriate restriction enzymes (see below), agarose gel purified and ligated into the reporter vector pBRAMScat2, which contains the thymidine kinase promoter (30 
Results
Identification and localization of polymorphic loci
PCR-SSCP screening of the 5Ј region of the mEH gene was accomplished using the five primer sets shown in Table I , panel A. Using this approach, no polymorphisms were identified in the two-sample sets which encompassed the region spanning from -193 to ϩ185 of the mEH gene (data not shown). However, analysis of 24 genomic DNA samples suggested that three of the five regions contained polymorphic loci. Figure 1A , an autoradiogram obtained from the SSCP assessment of the region spanning -430 to -165, demonstrated a complex banding pattern suggesting the presence of multiple polymorphic sites. In contrast, screening the regions -743 to -538 ( Figure 1B ) and -613 to -370 ( Figure 1C ), demonstrated simple banding patterns implying that fewer polymorphisms were present. DNA sequence was determined for putative polymorphic regions in order to identify the exact polymorphic locations and base substitutions. Seven polymorphic sites were identified, and the positions with base substitutions (shown in Figure 2 ) are as follows: -200C/T, -259C/T, -290T/G, -362A/G, -399T/ C, -613T/C, and -699T/C. PCR cycle sequencing enabled the identification of polymorphic sites and determination of genotype from a single reaction, as shown for four individuals at the -362A/G site ( Figure 3) . In this example, individual #1 is a heterozygote, #2 and #3 are homozygous -362G, and #4 is homozygous -362A.
Frequency analysis
To assess polymorphic site frequencies, genomic DNA samples from 51 individuals were genotyped by RFLP or COP analysis. RFLP characterization was employed for the polymorphic sites located at -200 (Mae III), -259 (Ssp I), -290 (Ban I), -399 (Bsl I), -613 (Nhe I) and -699 (Dde I). From this analysis we concluded that the polymorphic allele frequencies were not equal. For instance, variant residues -200T, -259T and -290G were detected in 90/102 alleles analysed (88%). Likewise, the polymorphic residues -613C and -699C were the predominant variants, observed in 69/102 alleles (68%). RFLP analysis of the DNA samples revealed a frequency of~82% (83/102) for the -399C variant.
389
Because a diagnostic restriction site was not present, the -362 polymorphism was analysed by COP analysis. Characteristic results of this analysis, obtained from the DNA of 15 individuals, are presented in Figure 4 . Agarose gels shown in Figure 4A and B (upper panels) demonstrate the presence of a prominent 271 bp product derived from the primers FPS3 and either RP-362C or RP-362T, respectively. Figure 4A and B (lower panels) present the autoradiograms obtained from the dried gels. The PCR bands seen in Figure 4A contained the radiolabeled RP-362C primer that is preferentially incorporated in products containing the 362G allele. Likewise, the autoradiogram in Figure 4B demonstrates the incorporation of the radiolabeled RP-362T primer, indicative of the 362A allele. From this Figure, it is concluded that individuals 1, 3, be independent from this group as can be deduced from the allelic frequencies reported above.
The 51 genomic DNA samples used for the genotyping analyses were obtained from 42 Caucasians, five Asians, three native Americans and one Hispanic. Although the sample size was small, no marked deviation was evident for any of the races with respect to the linkages reported above. Each of the polymorphic alleles at the 200 and 600 linkages was observed in Caucasians, Asians and native Americans. Both alleles at the -399 site were detected in the Caucasians, Asians and the Hispanic. These observations demonstrate that the polymorphisms and their associated linkages, are present in several races. However, because allele frequencies often vary among races and the small sample size for some ethnic groups in this study, only the 42 Caucasians were included for population analysis.
The polymorphic sites and linkages, allele frequencies, genotype frequencies and expected frequencies at HardyWeinberg equilibrium are shown in Table II . Frequency determinations for the variant nucleotides within both linkages and mEH genetic polymorphisms Table II . Polymorphic sites, allelic base substitutions (listed 3Ј to 5Ј), allelic frequency, genotypic frequency and frequencies predicted at Hardy-Weinberg equilibrium. The data are derived from 42 Caucasian genomic DNA samples (84 alleles).
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Transfection experiments
To assess the functional significance of these sequence variations, 12 mEH DNA fragments containing the polymorphic sites were cloned into pBRAMScat2 reporter vectors using the restriction sites shown in Figure 2 . The CAT ratios shown at the right of the figure were derived using the normalized CAT expression of clones from two to four experiments. CAT protein or SEAP activity was not detected in any of the mock transfections. Chimeric constructs containing either of the variant nucleotides at positions -200, -259, -290 and -399 demonstrated no consistent effect on CAT reporter expression. In contrast, constructs, which contain allelic variants at positions -362, -613 and -699, appeared to modulate CAT expression by~30% in an allele specific manner.
Discussion
We have identified and characterized seven polymorphic sites in the mEH proximal promoter region. Six of these base changes are transitions: five of the C/T class and one of the A/G type. The -290 G/T polymorphism was the only transversion identified in this study. These findings are in general agreement with previous estimates showing that transitions occur more frequently than transversions, with pyrimidines favored over purines (34) . The frequency of polymorphisms within this region of the human mEH gene (~1 per 100 bp) is slightly higher than the mean heterozygosity in the human genome of 1 per 250-300 bp estimated by Cooper et al. (35) . Four of the mEH gene polymorphic sites (-362, -399, -613 and -699) are apparent by comparing recently published sequences (15, 36) . The three polymorphic loci in the 200 linkage are not evident by comparative sequence analysis, probably due to the relatively low frequency of the CCT allele. An additional non-coding polymorphism, recently identified at residue ϩ66 (16), was not detected by the conditions employed in our SSCP analysis. To our knowledge, the presence of two separate linkage groups within a small promoter region, each containing three variant bases, represents an unusual finding. Promoters of numerous genes contain single polymorphic linkages. For instance, the cytochrome P450 CYP2E1 promoter contains five variant sites between -1259 and -771 bp, which were reported by Hayashi et al. (22) to exist in complete linkage disequilibrium. Linkage such as this is consistent with a gene conversion event (37) . Powers and Smithie (38) reported that multiple gene conversions between fetal γ and α-globin genes involve sequences Ͻ300 bp in length, and the linkages reported 391 here are within this size range. To consider gene conversion as a mechanistic explanation for our observations in the human mEH gene, homologous sequence must be present on the same chromosome. However, computer analyses of the DNA sequence currently deposited in Genbank (Release 102.0) reveals no unexpected sequence homologies to the mEH 5Ј upstream region.
The distal boundaries for the mEH gene linkages are not known. We have determined by DNA sequencing that the 200 linkage is not associated in a predictable manner with the variants at ϩ66 (16), nor the exons 3 and 4 coding polymorphisms (21) which reside Ͼ6500 bp downstream. However, as exemplified by the -399 site within the 600 linkage, this does not preclude continued linkage downstream of the ϩ66 site. The 5Ј boundary of the 600 linkage has not been determined.
The CAT expression data summarized in Figure 2 suggest that two polymorphic loci in the human mEH 5Ј region (-362 and -613) are each capable of modulating transcriptional activity by an average of~30%. The importance of the -613 site (clones 613T/613C, CAT ratio ϭ 0.70) is implied by the finding that no difference in the CAT expression ratio resulted when the -699 site was included in a similar construct (clones 699T/699C, CAT ratio ϭ 0.68). Inclusion of the -399 site within the -362 clones (see Figure 2) is also not likely to contribute to the observed variation because its presence alone did not alter the ratio of expression activities (clones 399C/ 399T, CAT ratio ϭ 1.08). It is possible that functional assessment of the entire linkage (-362 to -699) might reveal more significant differences in activity between the two alleles. Of interest, the 600 linkage is potentially not in HardyWeinberg equilibrium (χ 2 ϭ 2.96, 0.05 Ͻ P Ͻ 0.10). The analysis of a larger population may reveal statistically significant differences between observed and expected frequencies.
The molecular mechanisms responsible for the observed differences in transcriptional activity are unknown. We have analysed the mEH promoter and the polymorphic positions for the presence of transcription factor binding sites using the compilation of Boulikas (39) and the TransFac/MatInspector database (40) . The -290 site lies within a near consensus (12/ 13 bp) NF-1 recognition element (41) . However, no consistent effect on transcriptional activity was detected between the variant 200 linkage alleles containing this site. We were not able to identify putative transcription factor recognition elements within or near the remaining polymorphic positions characterized in this report. The higher measured transcriptional activities of polymorphic fragments containing G or C at the variant positions, compared to A or T in the respective positions, imply that the increase in hydrogen bonding potential at these sites may be a mechanistic factor. Future analysis of the mEH promoter region may help elucidate the molecular basis for these variations.
The in vivo effects of the 5Ј polymorphisms identified in the current study were examined in human liver samples that were previously characterized for mEH activity level using benzo[a]pyrene-4,5-oxide as substrate (42) . Each of the 5Ј polymorphisms described above was determined in five low (256 Ϯ 38 pmol/min/mg protein) and five high (1065 Ϯ 215 pmol/min/mg protein) activity liver samples and comparatively analysed. No significant correlation between genotype and mEH activity was demonstrated (data not shown). However, when the genotypes were given a numerical ranking based on the in vitro experimental data and plotted against liver activities, the slope of the regressed line was positive, as would be expected if there was a correlation. It is possible that analyses of a larger data set might yield more insight into a potential genotype/phenotype correlation.
Taken together, the functional effects of 5Ј upstream (this study) and coding region (21) mEH gene polymorphisms indicates that no single site accounts for the mEH activity variations observed in the general human population. However, combinations of 'low activity' alleles present in the mEH gene could account for the spectrum of phenotypic variation observed in humans. A working hypothesis supported with these findings is that allelic variation in the regulatory and structural regions of the mEH gene, and other factors function co-operatively to determine an individual's activity status. Possible undetermined factors include additional 5Ј polymorphisms, post-transcriptional regulation, gene induction by environmental agents and variation in the levels of transcriptional proteins required for mEH expression. The participation of these factors must be characterized more definitively in order to allow prediction of individual activities on the basis of these integrated phenomena. Genetic polymorphisms within the mEH gene locus likely represent an important mechanism for the modulation of carcinogen disposition that may ultimately influence individual susceptibility to cancer development.
